Published in Telemedicine Business Week, November 28th, 2007
"We included only adrenal tumors showing gradual persistent enhancement on CT and MRI performed at 15 and 5 min, respectively, after contrast material injection. Results Four tumors in four patients (three men and one woman;...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.